interleukin-1beta (163-171) has been researched along with acetylcysteine in 1 studies
| Studies (interleukin-1beta (163-171)) | Trials (interleukin-1beta (163-171)) | Recent Studies (post-2010) (interleukin-1beta (163-171)) | Studies (acetylcysteine) | Trials (acetylcysteine) | Recent Studies (post-2010) (acetylcysteine) |
|---|---|---|---|---|---|
| 192 | 3 | 74 | 14,580 | 1,046 | 5,960 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Curtin, WA; Given, HF; Mulhall, KJ | 1 |
1 other study(ies) available for interleukin-1beta (163-171) and acetylcysteine
| Article | Year |
|---|---|
Inhibition of polymethylmethacrylate particle-induced monocyte activation and IL-1beta and TNF-alpha expression by the antioxidant agent N-acetylcysteine.
Topics: Acetylcysteine; Antineoplastic Agents; Bone Cements; Free Radical Scavengers; Humans; In Vitro Techniques; Interleukin-1; Interleukin-1beta; Lymphokines; Macrophage Activation; Macrophages; Microscopy, Electron, Scanning; Monocytes; Particle Size; Peptide Fragments; Polymethyl Methacrylate; Tumor Necrosis Factor-alpha | 2002 |